Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*

DESCRIPTION Although approximately 85 million units of red blood cells (RBCs) are transfused annually worldwide, transfusion practices vary widely. The AABB (formerly, the American Association of Blood Banks) developed this guideline to provide clinical recommendations about hemoglobin concentration thresholds and other clinical variables that trigger RBC transfusions in hemodynamically stable adults and children. METHODS These guidelines are based on a systematic review of randomized clinical trials evaluating transfusion thresholds. We performed a literature search from 1950 to February 2011 with no language restrictions. We examined the proportion of patients who received any RBC transfusion and the number of RBC units transfused to describe the effect of restrictive transfusion strategies on RBC use. To determine the clinical consequences of restrictive transfusion strategies, we examined overall mortality, nonfatal myocardial infarction, cardiac events, pulmonary edema, stroke, thromboembolism, renal failure, infection, hemorrhage, mental confusion, functional recovery, and length of hospital stay. RECOMMENDATION 1: The AABB recommends adhering to a restrictive transfusion strategy (7 to 8 g/dL) in hospitalized, stable patients (Grade: strong recommendation; high-quality evidence). RECOMMENDATION 2: The AABB suggests adhering to a restrictive strategy in hospitalized patients with preexisting cardiovascular disease and considering transfusion for patients with symptoms or a hemoglobin level of 8 g/dL or less (Grade: weak recommendation; moderate-quality evidence). RECOMMENDATION 3: The AABB cannot recommend for or against a liberal or restrictive transfusion threshold for hospitalized, hemodynamically stable patients with the acute coronary syndrome (Grade: uncertain recommendation; very low-quality evidence). RECOMMENDATION 4: The AABB suggests that transfusion decisions be influenced by symptoms as well as hemoglobin concentration (Grade: weak recommendation; low-quality evidence).

[1]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[2]  B. Chaitman,et al.  Liberal or restrictive transfusion in high-risk patients after hip surgery. , 2011, The New England journal of medicine.

[3]  Ognjen Gajic,et al.  Incidence and transfusion risk factors for transfusion‐associated circulatory overload among medical intensive care unit patients , 2011, Transfusion.

[4]  J. Vincent,et al.  Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. , 2010, JAMA.

[5]  Sean M. O'Brien,et al.  Variation in use of blood transfusion in coronary artery bypass graft surgery. , 2010, JAMA.

[6]  M. Chagnon,et al.  Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study , 2010, Transfusion.

[7]  G. Foster,et al.  Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing , 2010, Transfusion.

[8]  Jiaquan Xu,et al.  Deaths: final data for 2007. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[9]  L. Coene,et al.  A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte‐depleted red blood cells , 2010, Vox sanguinis.

[10]  G. Schmid,et al.  Progress in Global Blood Safety for HIV , 2009, Journal of acquired immune deficiency syndromes.

[11]  Philip S Barie,et al.  Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care* , 2009, Critical care medicine.

[12]  D. Krysztof,et al.  Current incidence and residual risk of hepatitis B infection among blood donors in the United States , 2009, Transfusion.

[13]  D. Menon,et al.  The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury* , 2009, Critical care medicine.

[14]  H. Kehlet,et al.  The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery , 2009, Transfusion.

[15]  P. Marik,et al.  Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature* , 2008, Critical care medicine.

[16]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[17]  J. Lipton,et al.  A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation , 2007, Transfusion.

[18]  William Wijns,et al.  [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[19]  Angelo Branzi,et al.  Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. , 2007, European heart journal.

[20]  J. Collet,et al.  Transfusion strategies for patients in pediatric intensive care units. , 2007, The New England journal of medicine.

[21]  S. Brett,et al.  Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty , 2006, Vox sanguinis.

[22]  B. Hutton,et al.  Transfusion rates vary significantly amongst Canadian medical centres , 2005, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[23]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[24]  M. Levy,et al.  The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* , 2004, Critical care medicine.

[25]  Walter H Dzik,et al.  Emily Cooley Lecture 2002: transfusion safety in the hospital , 2003, Transfusion.

[26]  J. Vincent,et al.  Anemia and blood transfusion in critically ill patients. , 2002, JAMA.

[27]  J. Duguid,et al.  Guidelines for the clinical use of red cell transfusions , 2001, British journal of haematology.

[28]  Stephen MacMahon,et al.  Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies , 2001, The Lancet.

[29]  A E Voytovich,et al.  Transfusion errors in New York State: an analysis of 10 years' experience , 2000, Transfusion.

[30]  Jerod M. Loeb,et al.  To err is human: an interview with the Institute of Medicine's Linda Kohn. , 2000 .

[31]  W. Vaughn,et al.  Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome , 1999, Transfusion.

[32]  P. Lotke,et al.  Predonated autologous blood transfusions after total knee arthroplasty: immediate versus delayed administration. , 1999, The Journal of arthroplasty.

[33]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[34]  J. Magaziner,et al.  A pilot randomized trial comparing symptomatic vs. hemoglobin‐level‐ driven red blood cell transfusions following hip fracture , 1998, Transfusion.

[35]  W. Pevec,et al.  A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients. , 1997, American journal of surgery.

[36]  J. Linden,et al.  Decrease in frequency of transfusion fatalities , 1997, Transfusion.

[37]  J. Berlin,et al.  Effect of anaemia and cardiovascular disease on surgical mortality and morbidity , 1996, The Lancet.

[38]  Andrew D. Rosenberg,et al.  Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.

[39]  M. Popovsky,et al.  Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study , 1996, Immunohematology.

[40]  M. Urashima,et al.  Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage , 1996, Transfusion.

[41]  J. Marshall,et al.  Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group. , 1995, JAMA.

[42]  Arthur S Slutsky,et al.  Transfusion requirements in critical care : a pilot study , 1995 .

[43]  A. Giovanetti,et al.  Use of blood products for elective surgery in 43 European hospitals , 1994, Transfusion medicine.

[44]  R. Weintraub,et al.  Comparison of two transfusion strategies after elective operations for myocardial revascularization. , 1992, The Journal of thoracic and cardiovascular surgery.

[45]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[46]  G. Moss,et al.  Limits of cardiac compensation in anemic baboons. , 1988, Surgery.

[47]  R. Greenhalgh,et al.  Effect of early blood transfusion on gastrointestinal haemorrhage , 1986, The British journal of surgery.

[48]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[49]  J. Newell,et al.  Influence of hematocrit on cardiopulmonary function after acute hemorrhage. , 1986, The Journal of trauma.

[50]  A. Geha,et al.  Response of the hypertrophied heart to acute anemia and coronary stenosis. , 1978, Surgery.

[51]  S. Hagl,et al.  The effect of hemodilution on regional myocardial function in the presence of coronary stenosis , 1977, Basic Research in Cardiology.

[52]  H. Watson,et al.  British Committee for Standards in Haematology , 1969 .

[53]  J. Davis,et al.  The Red Blood Cell , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[54]  E. Topley,et al.  The Illness of Trauma , 1956, The British journal of clinical practice.

[55]  J. Carson,et al.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2012, The Cochrane database of systematic reviews.

[56]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[57]  J. Bom,et al.  Confounding by indication, an underestimated problem in clinical transfusion research , 2010 .

[58]  M. Harlow.  Food and Drug Administration Center for Biologics Evaluation and Research , 2003 .

[59]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[60]  L. Kohn.  To err is human: an interview with the Institute of Medicine's Linda Kohn. , 2000, The Joint Commission journal on quality improvement.

[61]  J. Galante,et al.  An analysis of blood management in patients having a total hip or knee arthroplasty. , 1999, The Journal of bone and joint surgery. American volume.

[62]  C. Martin,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[63]  Raúl E. López,et al.  Lightning fatalities, injuries, and damage reports in the United States, 1959-1994 , 1997 .

[64]  GrADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2022 .